Evidence map›Paper›PMID 42720120›Full record

ArticleCell biochemistry and function2026

Analysis of the Role of N-Linked Glycans on Human CD1d Molecules.

Syamdas Bandyopadhyay, Sayantan Pradhan

Abstract read
In one paragraph

Article in Cell biochemistry and function, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Syamdas BandyopadhyayDepartment of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, USA.ORCID https://orcid.org/0000-0002-4263-9430
Sayantan PradhanDepartment of Chemistry, Jadavpur University, Jadavpur, Kolkata, West Bengal, India.ORCID https://orcid.org/0000-0003-4884-7772

Funding

Yale University, New Haven, USA
6 · The paper itself

Abstract

CD1d is a cell-surface expressed glycoprotein that presents a variety of lipid and glycolipid antigens to invariant natural killer T-cells (iNKT). We have examined the role of the N-linked glycans on the human CD1d (hCD1d) in modulating the responses of iNKT cells using a combination of cell-free, cell-based assays and in silico analyses. Deficiency of one or more glycans on hCD1d diminished the activation of iNKT cells. Soluble glycan mutants did not have significant differences in terms of binding to the nickel-coated 96-well plates. Our cell-free assay, together with docking and MM-GBSA analyses, confirms that Glycan 1 and Glycan 2 are critical determinants of optimal iNKT cell activation. Taken together, our data emphasized an essential role of the hCD1d N-linked glycans in modulating iNKT cell response.

Indexed as

Antigens, CD1dNatural Killer T-CellsPolysaccharidesGlycosylationHumansMolecular Docking SimulationAntigens, CD1dCD1D protein, humanPolysaccharidescell surface receptorglycosylationhCD1diNKT cellsα‐GalCer

Identifiers

PMID42720120
PMCPMC13560098

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.